Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 26,389 | 29,248 | 36,799 | 28,424 | 22,169 |
| Cost of Goods | 4,320 | 29,553 | 2,684 | 4,991 | 7,150 |
| Gross Profit | 22,069 | -305 | 34,115 | 23,433 | 15,019 |
| Operating Expenses | 80,827 | 90,391 | 78,381 | 88,384 | 88,768 |
| Operating Income | -58,438 | -90,143 | -43,582 | -63,960 | -73,599 |
| Interest Expense | 8,147 | 8,273 | 7,998 | 8,538 | 6,481 |
| Other Income | -2,186 | 1,740 | 1,953 | 4,021 | 1,984 |
| Pre-tax Income | -68,771 | -96,676 | -49,627 | -68,477 | -78,096 |
| Net Income Continuous | -68,771 | -96,676 | -49,627 | -68,477 | -78,096 |
| Minority Interests | N/A | 0 | N/A | -2,273 | 60 |
| Net Income | $-68,771 | $-96,676 | $-49,627 | $-66,204 | $-78,156 |
| EPS Basic Total Ops | -0.88 | -1.24 | -0.68 | -0.97 | -1.17 |
| EPS Basic Continuous Ops | -0.88 | -1.24 | -0.68 | -1.01 | -1.16 |
| EPS Diluted Total Ops | -0.88 | -1.24 | -0.68 | -0.97 | -1.17 |
| EPS Diluted Continuous Ops | -0.88 | -1.24 | -0.68 | -1.01 | -1.16 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -0.88 | -1.24 | -0.68 | -0.92 |
| EBITDA(a) | $-57,939 | $-89,759 | $-43,114 | $-60,416 | $-73,069 |